87. 肺静脈閉塞症／肺毛細血管腫症
［臨床試験数：3，薬物数：4（DrugBank：3），標的遺伝子数：4，標的パスウェイ数：43］
Searched query = "Pulmonary veno-occlusive disease", "Pulmonary capillary hemangiomatosis", "PVOD", "PCH"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-UMIN000020543 | 2015/03/01 | 13/01/2016 | Efficacy of imatinib for the treatment of pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis | pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis | Oral administration of imatinib | National Hospital Organization Okayama Medical Center | NULL | Complete: follow-up complete | 18years-old | Not applicable | Male and Female | 8 | Not applicable | Japan | |
| 2 | NCT00891527 (ClinicalTrials.gov) | October 2008 | 30/4/2009 | Pilot Study Using Avastin and Gleevec to Treat the Progression of Intraluminal Pulmonary Vein Stenosis | Adjunct Targeted Biologic Inhibition in Children With Multivessel Intraluminal Pulmonary Vein Stenosis | Pulmonary Veno Occlusive Disease | Drug: Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec) | Boston Children's Hospital | NULL | Completed | N/A | N/A | All | 50 | Phase 1;Phase 2 | United States |
| 3 | NCT00563498 (ClinicalTrials.gov) | July 2004 | 21/11/2007 | Effects on Glutamine on the Outcome of Allogeneic Bone Marrow Transplant Recipients | A Randomized Control Studies on the Effects of Glutamine on the Clinical Outcome of Bone Marrow Transplant Recipients With Special Reference to Veno-occlusive Disease and Mucositis. | Pulmonary Veno-Occlusive Disease;Hepatic Veno-Occlusive Disease;Mucositis | Drug: Glutamine | Hospital Authority, Hong Kong | The University of Hong Kong;Fresienius Kabi HK Ltd | Recruiting | 18 Years | N/A | Both | 40 | N/A | China |